It is estimated that up to 80% of clinical studies fail to recruit a sufficient number of participants. These failures waste valuable resources and time; delaying new treatments from reaching patients.
Responsible recruitment is supported by our proprietary ”No Patients - No Payment” risk sharing program, through which we give our assurance that your enrolment goals, budgets, and timelines will be met.
By adding sites and utilizing our referral networks in CEE, we recruit at 2-3X the industry average
Our collaborative, and customized approach accelerates the initiation of your trial
Site feasibility: working with Cromos Pharma allows you access to the most highly qualified clinical trial sites
Established network of KOLs and Investigators: allows us to leverage existing contacts, shortening timelines and minimizing risks
Find out more about availing of Cromos Pharma’s No Patients No Payment offer by emailing